![Jesse S. Rosas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jesse S. Rosas
Plus aucun poste en cours
Profil
Jesse S.
Rosas is a Director of Signalife, Inc. He has been a Consultant of Rosas & Associates since June 2006.
Mr. Rosas has over 25 years of experience in accounting, tax planning, tax process reeingineering and compliance services, mergers & acquisitions, reorganization and liquidations, audit and internal control compliance and documentation and public company auditing.
From April 2002 to May 2004, Mr. Rosas was a Consultant of Rosas & Associates.
He was Director of Southern California Operations for Jefferson Wells International from June 2004 to May 2006.
Mr. Rosas worked at Arthur Andersen LLP from July 1982 to March 2002, including Senior Principal.
He was Chairman of the School of Business and Economic Minority Business Program at California State University, Northridge for over 15 years.
He was Treasurer and an Executive Committee Member of the Economic Development Alliance of the San Fernando Valley and a Director of the San Fernando Valley Economic Development Corp.
He received a BS degree in Business Administration from California State University, Northridge.
Anciens postes connus de Jesse S. Rosas
Sociétés | Poste | Fin |
---|---|---|
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | Directeur/Membre du Conseil | 10/06/2009 |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
Signalife, Inc.
![]() Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | Health Technology |